Clinical Trial Update: Clinical Trial of BMS-986504 in Recurrent GBM Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating BMS-986504 in patients with recurrent glioblastoma (WHO Grade IV) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• BMS-986504

Snippet

Sponsor: Nader Sanai | Conditions: Glioblastoma WHO Grade IV | EARLY_Phase 1 | Status: RECRUITING